赛拓动力学

最新新闻

• 评级变动
  Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $102
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• Wells Fargo Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $105
  \u5e02\u573a\u8d44\u8baf · 2026/10/4
• 评级变动
  B. Riley Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
  TipRanks · 2026/7/31
• Cytokinetics(CYTK.US) Officer Sells US$7.34 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $112
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/8/27
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
  TipRanks · 2026/9/10
• 评级变动
  A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $85 to $140
  \u5e02\u573a\u8d44\u8baf · 2026/9/1
• 评级变动
  RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• Form 144 | Cytokinetics(CYTK.US) Insider Proposes to Sell 7.09 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  B. Riley Securities Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $146
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $140
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $103
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• 评级变动
  Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/8/14

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。